HHS to FDA: Resume EUA Review of COVID-19 LDTs, And Do It Fast by Glenn S. Demby | Dec 1, 2020 | Articles, Essential, Industry Buzz-lir, Inside the Lab Industry-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register
HHS Orders FDA to Resume EUA Review of Laboratory Developed Tests for COVID-19 by Glenn S. Demby | Nov 24, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet, The Business of Testing-dtet... This content is for Paid Members only.Login Register
What a Biden Administration Might Portend for Regulation of Laboratory Developed Tests by Glenn S. Demby | Nov 17, 2020 | Articles, Essential, FDA-nir, National Lab Reporter... This content is for Paid Members only.Login Register
Agency Temporarily Allows Modifications of Influenza and RSV Tests Without Premarket Notification by Glenn S. Demby | Nov 3, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
FDA Pulls the Plug on EUA Review of Laboratory Developed Tests for COVID-19 by Glenn S. Demby | Nov 2, 2020 | Articles, Clinical Diagnostics Insider, Coronavirus, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.Login Register